Elham Ghaedi

Dr. Elham Ghaedi

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2022 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
MSMohammad Sadegh Soltani-Zangbar
Mohammad Sadegh Soltani-Zangbar
FPForough Parhizkar
Forough Parhizkar
Elham GhaediElham Ghaedi
Elham Ghaedi
ATAli Tarbiat
Ali Tarbiat
RMRoza Motavalli
Roza Motavalli
MYMehdi Yousefi
Mehdi Yousefi
Background: The COVID-19 pandemic has become the world’s main life-threatening challenge in the third decade of the twenty-first century. Numerous studies have been conducted on SARS-CoV2 virus structure and pathogenesis to find reliable treatments and vaccines. The present study aimed to evaluate the immune-phenotype and IFN-I signaling pathways of COVID-19 patients with mild and severe conditions. Material and methods: A total of 100 COVID-19 patients (50 with mild and 50 with severe conditions) were enrolled in this study. The frequency of CD4 + T, CD8 + T, Th17, Treg, and B lymphocytes beside NK cells was evaluated using flow cytometry. IFN-I downstream signaling molecules, including JAK-1, TYK-2, STAT-1, and STAT-2, and Interferon regulatory factors (IRF) 3 and 7 expressions at RNA and protein status were investigated using real-time PCR and western blotting techniques, respectively. Immune levels of cytokines (e.g., IL-1β, IL-6, IL-17, TNF-α, IL-2R, IL-10, IFN-α, and IFN-β) and the existence of anti-IFN-α autoantibodies were evaluated via enzyme-linked immunosorbent assay (ELISA). Results: Immune-phenotyping results showed a significant decrease in the absolute count of NK cells, CD4 + T, CD8 + T, and B lymphocytes in COVID-19 patients. The frequency of Th17 and Treg cells showed a remarkable increase and decrease, respectively. All signaling molecules of the IFN-I downstream pathway and IRFs (i.e., JAK-1, TYK-2, STAT-1, STAT-2, IRF-3, and IRF-7) showed very reduced expression levels in COVID-19 patients with the severe condition compared to healthy individuals at both RNA and protein levels. Of 50 patients with severe conditions, 14 had anti-IFN-α autoantibodies in sera. Meanwhile, this result was 2 and 0 for patients with mild symptoms and healthy controls, respectively. Conclusion: Our results indicate a positive association of the existence of anti-IFN-α autoantibodies and immune cells dysregulation with the severity of illness in COVID-19 patients. However, comprehensive studies are necessary to find out more about this context.

12 December 2024 in Cell Biochemistry and Biophysics
Verified
Journal Article
Closed access
PDF file
FBFarhad Bordbar
Farhad Bordbar
ARAmir Rigi
Amir Rigi
MMMahsa Vafaei Mastanabad
Mahsa Vafaei Mastanabad
FRFattah Rohani
Fattah Rohani
Elham GhaediElham Ghaedi
Elham Ghaedi
Salar Momen MaraghehSalar Momen Maragheh
Salar Momen Maragheh

20 November 2023 in Razi Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
FSFahimeh Saeifar
Fahimeh Saeifar
Salar Momen MaraghehSalar Momen Maragheh
Salar Momen Maragheh
Elham GhaediElham Ghaedi
Elham Ghaedi
SKSayyed Mohammadmatin Khademi
Sayyed Mohammadmatin Khademi
SDSaeid Dabirifar
Saeid Dabirifar
HSHossein Soltanzade
Hossein Soltanzade
Background & Aims: Diabetes as a heterogeneous disease is characterized by a decrease in insulin sensitivity and a defect in insulin secretion. In general, diabetes is divided into four groups, type 1 diabetes, type 2 diabetes, gestational diabetes, and diabetes of various causes. To be Emerging evidence suggests that common and rare genetic polymorphisms can ...